ATE520976T1 - Verfahren zur gewinnung eines schädlichen oxidationshauptmittels aus zigarettenrauch - Google Patents

Verfahren zur gewinnung eines schädlichen oxidationshauptmittels aus zigarettenrauch

Info

Publication number: ATE520976T1
Authority: AT; Austria
Prior art keywords: oxidant; cigarette smoke; smoke; cigarette; relatively stable
Prior art date: 2001-06-22

Application number

AT02712239T

Other languages

English (en)

Inventor

Indu Chatterjee

Original Assignee

Council Scient Ind Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-06-22

Filing date

2002-01-31

Publication date

2011-09-15

2002-01-31 Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res

2011-09-15 Application granted granted Critical

2011-09-15 Publication of ATE520976T1 publication Critical patent/ATE520976T1/de

Links

239000007800 oxidant agent Substances 0.000 title abstract 6
235000019504 cigarettes Nutrition 0.000 title abstract 5
239000000779 smoke Substances 0.000 title abstract 5
238000000034 method Methods 0.000 title abstract 2
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
230000004792 oxidative damage Effects 0.000 abstract 2
230000000391 smoking effect Effects 0.000 abstract 2
ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
229930003268 Vitamin C Natural products 0.000 abstract 1
239000006286 aqueous extract Substances 0.000 abstract 1
238000003556 assay Methods 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002939 deleterious effect Effects 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
231100001261 hazardous Toxicity 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000002955 isolation Methods 0.000 abstract 1
230000001590 oxidative effect Effects 0.000 abstract 1
230000006318 protein oxidation Effects 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
235000019154 vitamin C Nutrition 0.000 abstract 1
239000011718 vitamin C Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B15/00—Handkerchiefs
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B13/00—Baby linen
- A41B13/10—Bibs
- A41B13/103—Bibs with a pocket
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A41D13/00—Professional, industrial or sporting protective garments, e.g. surgeons' gowns or garments protecting against blows or punches
- A41D13/04—Aprons; Fastening devices for aprons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B2300/00—Details of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
- A41B2300/30—Closures
- A41B2300/32—Closures using hook and loop-type fasteners
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B2300/00—Details of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
- A41B2300/30—Closures
- A41B2300/324—Closures using snap fasteners
- A—HUMAN NECESSITIES
- A41—WEARING APPAREL
- A41B—SHIRTS; UNDERWEAR; BABY LINEN; HANDKERCHIEFS
- A41B2300/00—Details of shirts, underwear, baby linen or handkerchiefs not provided for in other groups of this subclass
- A41B2300/30—Closures
- A41B2300/33—Closures using straps or ties

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Textile Engineering (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Physics & Mathematics (AREA)
General Physics & Mathematics (AREA)
Immunology (AREA)
Pathology (AREA)
Veterinary Medicine (AREA)
Analytical Chemistry (AREA)
Public Health (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Toxicology (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Manufacture Of Tobacco Products (AREA)
Silicon Compounds (AREA)
Saccharide Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Cigarettes, Filters, And Manufacturing Of Filters (AREA)

AT02712239T 2001-06-22 2002-01-31 Verfahren zur gewinnung eines schädlichen oxidationshauptmittels aus zigarettenrauch ATE520976T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN701DE2001		2001-06-22
PCT/IN2002/000019 WO2003000633A2 (en)	2001-06-22	2002-01-31	A process for the isolation of a major harmful oxidant from cigarette smoke

Publications (1)

Publication Number	Publication Date
ATE520976T1 true ATE520976T1 (de)	2011-09-15

Family

ID=11097075

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02712239T ATE520976T1 (de)	2001-06-22	2002-01-31	Verfahren zur gewinnung eines schädlichen oxidationshauptmittels aus zigarettenrauch

Country Status (11)

Country	Link
US (2)	US6782891B2 (de)
EP (1)	EP1402253B1 (de)
JP (1)	JP4094545B2 (de)
KR (4)	KR100868687B1 (de)
CN (1)	CN100495028C (de)
AT (1)	ATE520976T1 (de)
AU (1)	AU2002232115A1 (de)
CA (1)	CA2451504C (de)
ES (1)	ES2371598T3 (de)
PT (1)	PT1402253E (de)
WO (1)	WO2003000633A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100868687B1 (ko) *	2001-06-22	2008-11-13	카운실 오브 사이언티픽 엔드 인더스트리얼 리서치	담배 연기에서 주요 유해성 산화제를 분리하는 방법
WO2005099493A2 (en) *	2004-04-14	2005-10-27	Philip Morris Products S.A.	Reduction of phenolic compound precursors in tobacco
JP4776474B2 (ja) *	2006-08-30	2011-09-21	正喜服部	生薬組成物
JP5259970B2 (ja) *	2007-03-30	2013-08-07	学校法人九州文化学園	薬物依存症治療剤
WO2014062677A1 (en) *	2012-10-15	2014-04-24	Kemin Industries, Inc.	A blend of green and black extracts for the promotion of health benefits
CN111272938A (zh) *	2020-03-19	2020-06-12	中国烟草总公司郑州烟草研究院	一种电子烟烟液中水分、烟碱、丙二醇和丙三醇的同时测定方法
CN114295430B (zh) *	2022-02-15	2024-08-09	云南中烟工业有限责任公司	一种气体分段捕集装置及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2559338C2 (de)	1975-12-31	1984-09-27	Th. Kieserling & Albrecht Gmbh & Co, 5650 Solingen	Schälmaschine
US4140003A (en) *	1978-05-10	1979-02-20	Federal Trade Commission	Cigarette smoking machine
US5854000A (en) *	1995-11-15	1998-12-29	Alteon Inc.	Methods for measurement predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts
KR100868687B1 (ko) *	2001-06-22	2008-11-13	카운실 오브 사이언티픽 엔드 인더스트리얼 리서치	담배 연기에서 주요 유해성 산화제를 분리하는 방법

2002
- 2002-01-31 KR KR1020037016754A patent/KR100868687B1/ko not_active Expired - Lifetime
- 2002-01-31 CN CNB028162153A patent/CN100495028C/zh not_active Expired - Lifetime
- 2002-01-31 KR KR1020087003581A patent/KR20080022233A/ko not_active Withdrawn
- 2002-01-31 ES ES02712239T patent/ES2371598T3/es not_active Expired - Lifetime
- 2002-01-31 JP JP2003506839A patent/JP4094545B2/ja not_active Expired - Lifetime
- 2002-01-31 EP EP02712239A patent/EP1402253B1/de not_active Expired - Lifetime
- 2002-01-31 PT PT02712239T patent/PT1402253E/pt unknown
- 2002-01-31 WO PCT/IN2002/000019 patent/WO2003000633A2/en not_active Ceased
- 2002-01-31 CA CA2451504A patent/CA2451504C/en not_active Expired - Lifetime
- 2002-01-31 AT AT02712239T patent/ATE520976T1/de active
- 2002-01-31 AU AU2002232115A patent/AU2002232115A1/en not_active Abandoned
- 2002-02-13 US US10/076,033 patent/US6782891B2/en not_active Expired - Lifetime
2004
- 2004-01-08 US US10/754,025 patent/US6929012B2/en not_active Expired - Lifetime
2008
- 2008-01-15 KR KR1020080004583A patent/KR20080015902A/ko not_active Ceased
- 2008-01-15 KR KR1020080004584A patent/KR20080011724A/ko not_active Ceased

Also Published As

Publication number	Publication date
AU2002232115A1 (en)	2003-01-08
KR20080011724A (ko)	2008-02-05
EP1402253B1 (de)	2011-08-17
US6782891B2 (en)	2004-08-31
EP1402253A2 (de)	2004-03-31
CN1555487A (zh)	2004-12-15
CA2451504C (en)	2011-01-18
KR20080015902A (ko)	2008-02-20
KR100868687B1 (ko)	2008-11-13
US20030111087A1 (en)	2003-06-19
WO2003000633A3 (en)	2003-05-08
KR20080022233A (ko)	2008-03-10
US20040204617A1 (en)	2004-10-14
CA2451504A1 (en)	2003-01-03
US6929012B2 (en)	2005-08-16
ES2371598T3 (es)	2012-01-05
JP2005502857A (ja)	2005-01-27
KR20040019316A (ko)	2004-03-05
WO2003000633A2 (en)	2003-01-03
PT1402253E (pt)	2011-09-29
JP4094545B2 (ja)	2008-06-04
CN100495028C (zh)	2009-06-03

Similar Documents

Publication	Publication Date	Title
Zappacosta et al.	1999	Effect of smoking one cigarette on antioxidant metabolites in the saliva of healthy smokers
NO20014534D0 (no)	2001-09-18	Fremgangsmåte ved adskillelse av proteiner
ATE285809T1 (de)	2005-01-15	Vorrichtung zur verabreichung einer substanz
MXPA04000062A (es)	2004-05-21	Miembros de drenaje extensibles para conectar a tierra la proteccion por interferencia electromagnetica/interferencia por radiofrecuencia.
ATE373422T1 (de)	2007-10-15	Mikroemulsionbildende herbizidkonzentrate, mikroemulsionen und verfahren
WO2002044156A3 (en)	2002-10-17	Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
HK1053972A1 (zh)	2003-11-14	聚甘氨酸胺基取代的阳离子寡聚合物肺表面活性剂
EA200201214A1 (ru)	2003-06-26	Замещенные тиоацетамиды
BG66103B1 (bg)	2011-04-29	Кондензирани пиролокарбазоли
WO2002069949A3 (en)	2003-06-05	Combination therapy for reduction of toxycity of chemotherapeutic agents
DE60119896D1 (de)	2006-06-29	Verwendung von pramipexol zur behandlung von tabak/nikotin abhängigkeit
DE60025008D1 (de)	2006-01-26	Bestimmung von adrenomedullin-bindenden proteinen
TR200301723T4 (tr)	2004-02-23	1,3 Dihidro-2H-indol-2 one türevleri ve bunların, arginin-vasopressin' in V1B veya V1B reseptörleri için bağ maddeleri olarak kullanımı
DE60234246D1 (de)	2009-12-17	Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
Panda et al.	2001	Cigarette smoke-induced protein oxidation and proteolysis is exclusively caused by its tar phase: prevention by vitamin C
PT1402253E (pt)	2011-09-29	Processo para o isolamento de um oxidante nocivo principal a partir do fumo de cigarro
WO2004099240A3 (en)	2005-03-24	Peptides and mixtures thereof for use in the detection of severe acute respiratory syndrome-associated coronavirus (sars)
AU1701402A (en)	2002-05-15	Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
ATE323154T1 (de)	2006-04-15	Verfahren zur isolierung eines proteins
DE50203283D1 (de)	2005-07-07	Zubereitung zur entfernung von abnormen keratinmaterial
WO2003001182A3 (en)	2005-04-21	Homocysteinylated transthyretin
EP1192952A3 (de)	2003-03-26	Ein NK-3 rezeptorantagonisten und ein ZNS-penetrierende NK-1 rezeptorantagonisten enthaltende Zusammensetzung zur Behandlung von Depression und Angst
EP1265073A3 (de)	2003-11-26	Verfahren zum Nachweis von der Plasmakonzentration von freien Arzneimitteln
ATE373717T1 (de)	2007-10-15	Pde8a und seine verwendung
EA200300448A1 (ru)	2003-10-30	Композиции, включающие соединения модафинила

Legal Events

Date

Code

Title

Description

2012-03-15

UEP

Publication of translation of european patent specification

Ref document number: 1402253

Country of ref document: EP